What is the 74° Congreso FEMECOG?
The 74° Congreso FEMECOG is the annual scientific congress organized by FEMECOG (Federación Mexicana de Colegios de Obstetricia y Ginecología), Mexico's leading federation of obstetrics and gynecology colleges. Scheduled for November 8-11, 2026, this congress represents one of Latin America's most significant gatherings of gynecologic professionals, with particular emphasis on gynecologic oncology including cervical, ovarian, and endometrial cancers.
As the 74th iteration of this prestigious event, the congress maintains its position as the premier platform for advancing gynecologic knowledge and practice in Mexico and the broader Latin American region. The event draws over 1,000 healthcare professionals annually, making it a critical venue for clinical education, research presentation, and professional networking in the gynecologic oncology field.
FEMECOG: The Organizing Federation
FEMECOG (Federación Mexicana de Colegios de Obstetricia y Ginecología) serves as the umbrella organization for Mexico's obstetrics and gynecology medical colleges. Founded to promote excellence in women's healthcare, FEMECOG coordinates educational initiatives, establishes clinical practice guidelines, and facilitates professional development across its member institutions.
The federation's annual congress has evolved into Mexico's most comprehensive gynecologic medical meeting, attracting specialists from across the Americas. FEMECOG's commitment to advancing gynecologic oncology reflects the organization's recognition of cancer as a leading cause of morbidity and mortality among women in Mexico and Latin America.
Core Therapeutic Focus Areas of the 74° Congreso FEMECOG
Cervical Cancer
The cervical cancer sessions at the 74° Congreso FEMECOG address comprehensive management strategies for cervicouterine malignancies. Key topics typically include:
- HPV vaccination programs and prevention strategies
- Screening methodologies including cytology and HPV testing
- Colposcopy techniques and biopsy protocols
- Surgical approaches: radical hysterectomy, trachelectomy, and lymphadenectomy
- Radiation therapy protocols and concurrent chemotherapy
- Immunotherapy advances in recurrent and metastatic disease
- Fertility preservation in young patients
- Quality of life considerations and survivorship care
Ovarian Cancer
Ovarian malignancy sessions focus on the complex challenges of diagnosis, staging, and treatment of epithelial and non-epithelial ovarian cancers. Expected content areas include:
- Biomarker development and genetic testing strategies
- Surgical staging and cytoreductive surgery techniques
- PARP inhibitor therapy and maintenance protocols
- Hereditary cancer syndromes: BRCA1/2 and Lynch syndrome
- Intraperitoneal chemotherapy administration
- Targeted therapies and antiangiogenic agents
- Management of platinum-resistant disease
- Palliative care integration in advanced disease
Endometrial Cancer
Endometrial cancer programming addresses the growing incidence of uterine malignancies, particularly in relation to obesity and metabolic disorders. Topics encompass:
- Risk stratification and molecular classification systems
- Minimally invasive surgical approaches
- Sentinel lymph node mapping techniques
- Hormone therapy for early-stage disease
- Immunotherapy in microsatellite instability-high tumors
- Management of synchronous ovarian and endometrial cancers
- Fertility-sparing treatments in young women
- Surveillance strategies for high-risk patients
Target Audience and Professional Demographics
The 74° Congreso FEMECOG attracts a diverse professional audience representing multiple subspecialties within gynecologic medicine. Primary attendees include:
- Gynecologic Oncologists: Board-certified specialists managing complex gynecologic malignancies
- General Gynecologists: Practitioners seeking oncology education to enhance their practice capabilities
- Obstetrics and Gynecology Residents: Trainees pursuing specialization in women's healthcare
- Medical Oncologists: Specialists involved in systemic therapy for gynecologic cancers
- Radiation Oncologists: Physicians specializing in radiotherapy for gynecologic malignancies
- Pathologists: Specialists in gynecologic pathology and molecular diagnostics
- Nurses and Allied Health Professionals: Healthcare team members providing specialized gynecologic cancer care
- Pharmaceutical Industry Representatives: Professionals involved in drug development and medical affairs
Geographic Reach and International Participation
While the 74° Congreso FEMECOG primarily serves Mexican healthcare professionals, its influence extends throughout Latin America and beyond. International participation includes delegates from:
- Central American countries: Guatemala, Honduras, El Salvador, Costa Rica, Panama
- South American nations: Colombia, Venezuela, Ecuador, Peru, Argentina, Chile
- Caribbean region: Dominican Republic, Puerto Rico, Cuba
- United States: Hispanic-serving medical centers and border region institutions
- Spain: Academic medical centers with Latin American collaborative programs
This international representation facilitates knowledge exchange and establishes collaborative research networks across the Spanish-speaking medical community.
Scientific Program Structure and Educational Format
Plenary Sessions
The 74° Congreso FEMECOG features comprehensive plenary sessions addressing cutting-edge developments in gynecologic oncology. These sessions typically include state-of-the-art lectures delivered by renowned international experts, providing attendees with the latest evidence-based treatment approaches.
Symposia and Workshops
Interactive educational formats include hands-on workshops covering surgical techniques, diagnostic procedures, and emerging technologies. Symposia focus on multidisciplinary approaches to complex cases, featuring panel discussions among experts from different specialties.
Poster Presentations and Research
The congress provides platforms for original research presentation through poster sessions and oral presentations. These venues allow investigators to share their findings and receive feedback from the international scientific community.
Industry Exhibition
A comprehensive exhibition showcases the latest pharmaceutical innovations, medical devices, and diagnostic technologies relevant to gynecologic oncology practice. This component facilitates interaction between healthcare providers and industry representatives.
Continuing Medical Education and Certification
The 74° Congreso FEMECOG provides extensive continuing medical education (CME) credits recognized by Mexican medical licensing authorities and international accrediting bodies. Participants can earn credits applicable toward:
- Mexican medical license renewal requirements
- Specialty board certification maintenance
- International CME recognition programs
- Institutional continuing education mandates
Educational objectives align with competency-based medical education principles, ensuring participants acquire practical knowledge applicable to their clinical practice.
Abstract Submission and Research Presentation Guidelines
The congress encourages submission of original research, clinical case reports, and innovative treatment protocols. Abstract categories typically include:
- Clinical research in gynecologic oncology
- Basic science and translational research
- Quality improvement initiatives
- Case reports and unusual presentations
- Educational innovations in gynecologic training
- Public health and prevention programs
Submission deadlines generally occur 3-4 months prior to the congress date, with peer review conducted by the scientific committee comprising recognized experts in gynecologic oncology.
Speaker Preparation and Presentation Excellence
Successful participation as a speaker at the 74° Congreso FEMECOG requires thorough preparation addressing both scientific content and presentation delivery. Key preparation elements include:
Content Development
Speakers must ensure their presentations reflect current evidence-based practice guidelines, incorporate recent literature reviews, and address practical clinical applications. Content should be tailored to the diverse educational backgrounds of attendees, from general gynecologists to subspecialty experts.
Cultural and Linguistic Considerations
Presentations at the 74° Congreso FEMECOG are typically delivered in Spanish, requiring speakers to consider linguistic nuances and cultural context relevant to Latin American healthcare systems. Medical terminology should align with regional usage patterns and clinical practice standards.
Technology Integration
Modern congress presentations increasingly incorporate multimedia elements, interactive components, and real-time audience engagement tools. Speakers should familiarize themselves with available technology platforms and prepare backup materials for technical contingencies.
Professional Development Support
Organizations like Leaderlix Health provide specialized support for healthcare professionals preparing to present at international medical congresses. Their services include presentation coaching, content review, and cultural adaptation guidance specifically designed for pharmaceutical and medical device industry professionals participating in events like the 74° Congreso FEMECOG. This type of professional preparation ensures speakers can effectively communicate their scientific messages while meeting the high standards expected at premier medical conferences.
Registration and Logistics Information
Registration for the 74° Congreso FEMECOG typically opens 6-8 months prior to the event date. Early registration often provides significant cost savings and guarantees access to popular sessions that may reach capacity limits.
Registration Categories
- FEMECOG member physicians: Discounted rates for federation members
- Non-member physicians: Standard professional registration
- Residents and fellows: Reduced rates for trainees
- International attendees: Pricing for participants from outside Mexico
- Allied health professionals: Specialized rates for nurses and other healthcare workers
- Industry representatives: Commercial registration for pharmaceutical and device company personnel
Venue and Accommodation
While the specific venue for the 2026 congress remains to be confirmed, FEMECOG typically selects major convention centers in prominent Mexican cities capable of accommodating over 1,000 attendees. Previous locations have included Mexico City, Guadalajara, and Cancún, offering attendees access to modern facilities and comprehensive accommodation options.
Impact on Clinical Practice and Patient Care
The 74° Congreso FEMECOG plays a crucial role in advancing gynecologic oncology care throughout Mexico and Latin America. The congress facilitates the dissemination of evidence-based treatment protocols, promotes adoption of innovative surgical techniques, and encourages implementation of comprehensive cancer care programs.
Attendees return to their practice settings equipped with updated knowledge that directly impacts patient outcomes. The congress contributes to reducing disparities in gynecologic cancer care by ensuring practitioners in diverse geographic regions have access to the latest therapeutic advances and diagnostic technologies.
Future Directions and Emerging Trends
The 74° Congreso FEMECOG 2026 is expected to address several emerging trends in gynecologic oncology, including precision medicine approaches, artificial intelligence applications in diagnostics, and telemedicine integration in cancer care delivery. These topics reflect the evolving landscape of women's healthcare and the need for adaptive clinical practice models.
The congress will likely emphasize multidisciplinary care coordination, patient-centered treatment approaches, and health equity considerations that are increasingly recognized as essential components of comprehensive cancer care.